Start of Coverage: 04-02-2008
Following JMT’s 4Q sales print, we update our model/forecasts raising FY20E EBITDA by +1% to €1,415m (post IFRS16, pre: +2% to €1,019m). We expect Biedronka’s +6.9% LFL beat to drive incremental operating leverage (pre-IFRS 16 4Q: +10bps) but be partially offset by higher central charges (4Q: -€23m).
Analyst: Nick Coulter
e-mail: nick.coulter@citi.com
| Analyst | Price target | Recommendation | Date |
| Nick Coulter | 14.00 € | Neutral | 15 Jan 2021 |
| Nick Coulter | 14.00 € | Neutral | 15 May 2020 |
| Nick Coulter | 15.20 € | Neutral | 10 Oct 2019 |
| Nick Coulter | 13.00 € | Neutral | 2 Jul 2018 |
| Nick Coulter | 15.00 € | Neutral | 11 Jun 2018 |
| Nick Coulter | 16.80 € | Neutral | 21 Oct 2016 |
| Pradeep Pratti | 14.50 € | Buy | 17 Apr 2015 |
| Pradeep Pratti | 11.00 € | Neutral | 25 Feb 2015 |
| Pradeep Pratti | 8.50 € | Neutral | 6 Jan 2015 |
| Pradeep Pratti | 8.80 € | Neutral | 30 Oct 2014 |
| Pradeep Pratti | 12.00 € | Neutral | 30 Jul 2014 |
| Pradeep Pratti | 12.80 € | Neutral | 10 Jul 2014 |
| Pradeep Pratti | 13.50 € | Neutral | 1 May 2014 |
| Alastair Johnston | 15.00 € | Buy | 26 Feb 2014 |
| Alastair Johnston | 16.15 € | Buy | 13 Jan 2014 |
| Alastair Johnston | 17.00 € | Buy | 1 Aug 2013 |
| Alastair Johnston | 20.00 € | Buy | 24 Jun 2013 |
| Alastair Johnston | 21.00 € | Buy | 25 Apr 2013 |
| Alastair Johnston | 18.20 € | Buy | 5 Apr 2013 |
| Alastair Johnston | 15.30 € | Buy | 26 Oct 2012 |
| Alastair Johnston | 14.20 € | Buy | 23 Sep 2011 |
| Alastair Johnston | 14.80 € | Buy | 19 Sep 2011 |
| Alastair Johnston | 16.00 € | Buy | 12 Jul 2011 |
| Alastair Johnston | 13.70 € | Buy | 11 Jan 2011 |
| Alastair Johnston | 12.50 € | Buy | 28 Oct 2010 |
| Alastair Johnston | 10.50 € | Buy | 23 Sep 2010 |
| Alastair Johnston | 9.00 € | Buy | 3 Mar 2010 |
| Alastair Johnston | 8.00 € | Buy | 5 Jan 2010 |
| Jerome Samuel | 5.10 € | Buy | 5 Mar 2009 |
| Jerome Samuel | 6.10 € | Buy | 14 Jan 2009 |
The information presented refers to recommendations issued by analysts that follow the Jerónimo Martins share. For more information, please read the Analysts Coverage section in this website’s Terms and Conditions.